Author

Alexander Dodoo

Observed names: A NO Dodoo, A. Dodoo, A. N. O. Dodoo, A.N.O. Dodoo, Alex Nii Oto Dodoo, Alexander N Dodoo, Alexander N O Dodoo, Alexander N. Dodoo, Alexander N. O. Dodoo, Alexander N.O. Dodoo, Alexander NO Dodoo, Alexander Nii Oto Dodoo, Dodoo, Alexander

Institution: Ghana Standards Authority

Observed institutions: Uppsala Monitoring Centre, University of London, University of Ghana, King's College London, University of the Witwatersrand, Korle Bu Teaching Hospital, World Health Organization, Ghana Standards Authority

ORCID: 0000-0003-1831-3008

Observed ORCID: 0000-0003-1831-3008

OpenAlex ID: A5081896845

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®

2016 · Haggar H. Ampadu, Jarno Hoekman, et al. · Drug Safety · 178

Medicines Regulation in Africa: Current State and Opportunities

2017 · Margareth Ndomondo-Sigonda, Jacqueline Miot, et al. · Pharmaceutical Medicine · 176

Specific features of medicines safety and pharmacovigilance in Africa

2011 · Ambrose O. Isah, Shanthi N. Pal, et al. · Therapeutic Advances in Drug Safety · 105

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns

2017 · Raymond A. Tetteh, Barbara A. Yankey, et al. · Drug Safety · 97

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population

2009 · William Kudzi, Alexander NO Dodoo, et al. · BMC Medical Genetics · 94

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

2009 · Alexander NO Dodoo, Carole Fogg, et al. · Malaria Journal · 93

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

2010 · William Kudzi, Alexander NO Dodoo, et al. · BMC Medical Genetics · 76

Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization

2013 · Ananda Amarasinghe, Steve Black, et al. · Vaccine · 49

The African Medicines Regulatory Harmonization Initiative: Progress to Date

2018 · Margareth Ndomondo-Sigonda, Jacqueline Miot, et al. · Medical Research Archives · 44

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

2014 · Christine G Maure, Alexander N Dodoo, et al. · Bulletin of the World Health Organization · 39

Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey

2015 · Comfort Kunak Suku, Geraldine Hill, et al. · Drug Safety · 36

Realities of paediatric pharmacotherapy in the developing world

2011 · K. Hoppu, S. Sri Ranganathan, et al. · Archives of Disease in Childhood · 34

Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique

2008 · Esperança Sevene, Alda Mariano, et al. · Drug Safety · 34

Profile of Adverse Events in Patients Receiving Treatment for Malaria in Urban Ghana: A Cohort-Event Monitoring Study

2014 · Alexander N. O. Dodoo, Carole Fogg, et al. · Drug Safety · 31

The role of generic medicines and biosimilars in oncology in low-income countries

2013 · L. Renner, F.A. Nkansah, et al. · Annals of Oncology · 31

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years

2016 · Edwin J. Asturias, Melinda Wharton, et al. · Vaccine · 30

Predictors of antibiotics co-prescription with antimalarials for patients presenting with fever in rural Tanzania

2013 · Mustafa Njozi, Mbaraka Amuri, et al. · BMC Public Health · 30

Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda

2019 · H. Hilda Ampadu, Kwaku Poku Asante, et al. · Malaria Journal · 29

Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana

2015 · Raymond A. Tetteh, Edmund T. Nartey, et al. · BMC Public Health · 29

Safety Monitoring of a New Pentavalent Vaccine in the Expanded Programme on Immunisation in Ghana

2007 · Alexander N O Dodoo, Lorna Renner, et al. · Drug Safety · 29

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study

2018 · Tom G. Jacobs, H. Hilda Ampadu, et al. · BMC Public Health · 26

A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals

2010 · Andy Stergachis, Rebecca JK Bartlein, et al. · Malaria Journal · 23

Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria

2021 · Thomas A. Anyorigiya, Sandra Castel, et al. · Malaria Journal · 22

The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance

2015 · Priya Bahri, Alexander N. Dodoo, et al. · Drug Safety · 21

Using classification tree modelling to investigate drug prescription practices at health facilities in rural Tanzania

2012 · Dan K Kajungu, Majige Selemani, et al. · Malaria Journal · 21

Works count: 63

Citation count: 1,615

H-index: 22

I10-index: 37